Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Drugs & Aging|March 10, 2010
Safety considerations of fluoroquinolones in the elderly: an updateRalf Stahlmann, Hartmut LodeDrugs & Aging|March 19, 2003
Fluoroquinolones in the elderly: safety considerationsRalf Stahlmann, Hartmut LodeGMS Infectious Diseases|May 7, 2020
Calculated initial parenteral treatment of bacterial infections: Safety and tolerabiltyRalf Stahlmann, Hartmut LodeDeutsches Arzteblatt International|April 29, 2020
Medication for COVID-19-an Overview of Approaches Currently Under StudyRalf Stahlmann, Hartmut LodeDeutsche Medizinische Wochenschrift (1946)|February 24, 2015
[Pharmacokinetics of antibiotics in obese and critical care patients]Ralf Stahlmann, Hartmut LodeInternational Journal of Antimicrobial Agents|October 7, 2008
Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical dataJudith Sendzik, Hartmut Lode, Ralf StahlmannInternational Journal of Antimicrobial Agents|December 26, 2009
Synergistic effects of dexamethasone and quinolones on human-derived tendon cellsJudith Sendzik, Mehdi Shakibaei, Monika Schäfer-Korting, et al.Archives of Toxicology|December 20, 2002
Children as a special population at risk--quinolones as an example for xenobiotics exhibiting skeletal toxicityRalf StahlmannThe American Journal of Medicine|March 31, 2010
Safety and tolerability of commonly prescribed oral antibiotics for the treatment of respiratory tract infectionsHartmut LodePageof 11